Earnings Feed
Start Free
Home/Filings/4/0001140361-09-013729
4//SEC Filing

Kang Y Michele 4

Accession 0001140361-09-013729

CIK 0001228627other
View on SEC.govCompany Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:09 PM ET

Size

11.1 KB

Accession

0001140361-09-013729

Insider Transaction Report

Form 4
Period: 2009-06-01
REXAHN PHARMACEUTICALS, INC.RNN
Kang Y Michele
Director
Transactions
  • Award

    Stock Options (right to buy)

    2009-06-01+20,000→ 20,000 total
    Exercise: $1.28Exp: 2019-06-01→ Common Stock (20,000 underlying)
Holdings

  • Stock Options (right to buy)

    Exercise: $1.47Exp: 2018-08-12→ Common Stock (150,000 underlying)
    150,000

  • Stock Options (right to buy)

    Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying)
    20,000
Footnotes (3)
  • [F1]These options vest and become exercisable in full on June 30, 2009.
  • [F2]30% of the options vest and become exercisable on August 12, 2009; another 30% of the options vest and become exercisable on August 12, 2010; and the remaining 40% of the options vest and became exercisable on August 12, 2011.
  • [F3]These options vest and become exercisable in full on June 1, 2010.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeother

Related Parties

1
  • filerCIK 0001361685

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:09 PM ET
Size
11.1 KB
View on SEC.gov